CjC 1295 with DAC 2 mg per bottle 1 vial is an injectable biopharmaceutical. It is a compound made up of GHRH (growth hormone releasing hormone) and DAC (drug affinity complex) bound together to form a single molecule. It contains the amino acid sequence of GHRH, which is necessary to stimulate the release of growth hormone in the body. CjC 1295 is used as a hormone-releasing agent to treat growth hormone deficiency in adults and children. DAC increases the stability and duration of action of the GHRH, so that the release of growth hormone can be sustained over a longer period of time. CjC 1295 is administered as an intramuscular or subcutaneous injection, and the recommended dosage is two mg per bottle of 1 vial.